Tellus Therapeutics, Inc Revenue

Biotechnology Research • 8 Davis Drive, Durham, United States • 1-10 Employees

Tellus Therapeutics, Inc revenue & valuation

Annual revenue	$1,100,000
Revenue per employee	$123,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$16,000,000

Key Contacts at Tellus Therapeutics, Inc

Eric Benner

Co-Founder, Chief Scientific Officer

Khadar Abdi

Director Of Research

Company overview

Headquarters	8 Davis Drive, Durham, NC 27713, US
Phone number	+19194914995
Website	tellustherapeutics.com
Keywords	Neonatology, Brain Injury, White Matter Injury
Founded	2018
Employees	1-10
Socials

Tellus Therapeutics, Inc Email Formats

Tellus Therapeutics, Inc uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@tellustherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@tellustherapeutics.com	100%

About Tellus Therapeutics, Inc

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Director

Entry

Employees by Department

Tellus Therapeutics, Inc has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Tellus Therapeutics, Inc's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-03-21	1	$16,000,000

Funding Insights

$16,000,000

Total funding amount

$16,000,000

Most recent funding amount

Number of funding rounds

Tellus Therapeutics, Inc Tech Stack

Discover the technologies and tools that power Tellus Therapeutics, Inc's digital infrastructure, from frameworks to analytics platforms.

ScrollMagic

JavaScript libraries

Google Maps

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Google Tag Manager

Tag managers

GoDaddy

Hosting

Frequently asked questions

Tellus Therapeutics, Inc is located in 8 Davis Drive, Durham, US.

You can reach Tellus Therapeutics, Inc at +19194914995.

Tellus Therapeutics, Inc generates an estimated annual revenue of $1,100,000. This revenue figure reflects the company's market position and business performance in its industry.

Tellus Therapeutics, Inc has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Tellus Therapeutics, Inc was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Tellus Therapeutics, Inc has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Tellus Therapeutics, Inc has raised a total of $16,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Tellus Therapeutics, Inc

Eric Benner

Co-Founder, Chief Scientific Officer

Khadar Abdi

Director Of Research

4.8

40,000 users